Liminatus Pharma, Inc. Class A Common Stock Cash Flow Quality Index
Liminatus Pharma, Inc. Class A Common Stock cash flow quality index. Liminatus Pharma, Inc. Class A Common Stock (LIMN) has a Cash Flow Quality Index of -0.28x as of December 2021. Operating cash flow of $-1.22 Million is below net income of $4.37 Million, suggesting accrual-heavy earnings not yet converted to cash. See Liminatus Pharma, Inc. Class A Common St leverage flexibility ratio to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Liminatus Pharma, Inc. Class A Common Stock (2021–2021)
Cash flow quality index of Liminatus Pharma, Inc. Class A Common Stock from 2021 to 2021. Historical Cash Flow Quality Index for Liminatus Pharma, Inc. Class A Common Stock across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore LIMN cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Liminatus Pharma, Inc. Class A Common Stock Cash Flow Quality Index by Year (2021–2021)
Liminatus Pharma, Inc. Class A Common Stock cash flow quality index by year from 2021 to 2021. Year-by-year earnings quality comparison for Liminatus Pharma, Inc. Class A Common Stock. For the full cash flow conversion analysis, see Liminatus Pharma, Inc. Class A Common St cash flow conversion.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2021 | -0.28x | $-1.22 Million | $4.37 Million | — |